ABDUL MAMDANI: Open Payments
NPI 1508195652 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 14 payments from 5 companies in 2025. Trend: 2023 $426 · 2024 $749 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $148 |
| ABBVIE INC. | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: IBSRELA, TREMFYA, ENTYVIO, SKYRIZI, XIFAXAN, LINZESS, RINVOQ.
Industry payments across NM — which companies pay providers there.
